Positive opinion supports reducing Libtayo dosing frequency from every three weeks to every six weeks after first 12 weeks of treatment Optional ...

How Is First-Line Treatment Changing? / advanced urothelial carcinoma, bladder cancer, cancer, cancer care, Cancer research, ...

Fluor worked with Bayer during site selection and is now handling early design. Detailed design, construction management and general contracting selections remain pending. 1,500 CONSTRUCTION JOBS ...

NEW ALBANY, Ohio — Bayer Pharmaceuticals on Friday announced a new manufacturing plant slated for New Albany, bringing hundreds of jobs to the region. Gov. Mike DeWine said the $2.2 billion plant ...

Bayer BAYN-2.38%decrease; down pointing triangle agreed to sell rights to its cancer drug Stivarga to Gruenenthal Group for up to 375 million euros ($430.7 million), the acquirer said Monday. The drug ...

Apollo-managed funds and affiliates have completed a €3 billion capital solution for Bayer, with KKR joining the transaction as a significant minority participant. Apollo originally announced the ...

NEW YORK and LEVERKUSEN, Germany, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates (“Apollo”) have successfully closed a €3 billion ...

- Bayer trades at 10.8x forward earnings, far below peers like Merck MRK--(100x) and AbbVie ABBV--(68.9x), reflecting litigation risks and uneven business segments. - Crop Science drove 3.5% sales ...

OMAHA (DTN) -- Bayer CropScience is asking a federal court to dismiss antitrust claims by Iowa-based Latham Quality Inc., arguing the company failed to show Bayer illegally used licensing agreements ...

Apollo funds and ⁠affiliates would take a minority, non-controlling stake in a new entity holding the LARC business, while Bayer keeps a majority stake and "complete operational control." Sign up here ...

OMAHA (DTN) -- Bayer Group has announced the company is consolidating its Roundup business into a new subsidiary, Ruveon LLC, which will oversee all aspects of the company's glyphosate business.